The president said he would promote more competition among pharmaceutical companies, but didn’t call for Medicare to directly negotiate lower prices or consumers to be able to import low-cost drugs.
The president said he would promote more competition among pharmaceutical companies, but didn’t call for Medicare to directly negotiate lower prices or consumers to be able to import low-cost drugs.